nPhase's SEC filing shows $15 million sold in its $30 million Series D

The clinical-data software company announced the closing of a $30 million round led by Viking Global on Nov. 2. Its Form D, which the SEC accepted late Tuesday, reports half that amount sold so far.

By · Published

Two banded stacks of U.S. dollar bills sit on a lab bench beneath an nPhase sign, beside test tubes and a glass flask.

The clinical-data software company announced the closing of a $30 million round led by Viking Global on Nov. 2. Its Form D, which the SEC accepted late Tuesday, reports half that amount sold so far.